My Quote Request
No products added yet
6505-00-172-3438
20 Products
BUTISERPAZIDE50
RESERPINE,BUTABARBITAL SODIUM,AND HYDROCHLOROTHIAZIDE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505001723438
NSN
6505-00-172-3438
BUTISERPAZIDE50
RESERPINE,BUTABARBITAL SODIUM,AND HYDROCHLOROTHIAZIDE EXTENDED-RELEASE TABLETS
NSN, MFG P/N
6505001723438
NSN
6505-00-172-3438
MFG
MCNEIL LAB INC MCNEIL PHARMACEUTICAL DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT AND 0.100 MILLIGRAMS RESERPINE ACTIVE INGREDIENT AND 30.000 MILLIGRAMS BUTABARBITAL SODIUM ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
SPECIAL FEATURES: COLOR ORANGE;LONG ACTION METHOD:EXTENDED RELEASE;ADMINISTRATION:ORAL NONCHEWABLE;PRIMARY CONTAINER TYPE:A/A;
Related Searches:
76289
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505001711188
NSN
6505-00-171-1188
76289
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505001711188
NSN
6505-00-171-1188
MFG
HOFFMANN-LA ROCHE INC.
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOX
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
LIBRIUM TEL-E-DOSE
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505001711188
NSN
6505-00-171-1188
LIBRIUM TEL-E-DOSE
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505001711188
NSN
6505-00-171-1188
MFG
HOFFMANN-LA ROCHE INC.
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOX
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00140-0003-49
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505001711188
NSN
6505-00-171-1188
NDC00140-0003-49
CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505001711188
NSN
6505-00-171-1188
MFG
HOFFMANN-LA ROCHE INC.
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: BOX
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00008-0313-02
ASPIRIN TABLETS,USP
NSN, MFG P/N
6505001711200
NSN
6505-00-171-1200
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.300 GRAMS ASPIRIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00182-1279-89
CEPHALEXIN CAPSULES,USP
NSN, MFG P/N
6505001711213
NSN
6505-00-171-1213
NDC00182-1279-89
CEPHALEXIN CAPSULES,USP
NSN, MFG P/N
6505001711213
NSN
6505-00-171-1213
MFG
GOLDLINE LABORATORIES GOVERNMENT SALES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CEPHALEXIN EQUIVALENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEPHALEXIN CAPSULES USP 500MG I.S. 100S
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 CAPSULES
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC51079-0605-20
CEPHALEXIN CAPSULES,USP
NSN, MFG P/N
6505001711213
NSN
6505-00-171-1213
NDC51079-0605-20
CEPHALEXIN CAPSULES,USP
NSN, MFG P/N
6505001711213
NSN
6505-00-171-1213
MFG
UDL LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CEPHALEXIN EQUIVALENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEPHALEXIN CAPSULES USP 500MG I.S. 100S
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 CAPSULES
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00054-8035-11
ALUMINUM HYDROXIDE GEL,USP
NSN, MFG P/N
6505001711219
NSN
6505-00-171-1219
NDC00054-8035-11
ALUMINUM HYDROXIDE GEL,USP
NSN, MFG P/N
6505001711219
NSN
6505-00-171-1219
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 PERCENTAGE, W/V ALUMINUM HYDROXIDE GEL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FLAVOR: ANY ACCEPTABLE
PHARMACEUTICAL VEHICLE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 25 BOTTLE
PRIMARY CONTAINER TYPE: BOTTLE
SECONDARY CONTAINER TYPE: BOX
TOTAL PRIMARY CONTAINER QUANTITY: 100
TOTAL SECONDARY CONTAINER QUANTITY: 4
Related Searches:
A.S.A. IDENTI-CODE
ASPIRIN TABLETS,USP
NSN, MFG P/N
6505001711373
NSN
6505-00-171-1373
A.S.A. IDENTI-CODE
ASPIRIN TABLETS,USP
NSN, MFG P/N
6505001711373
NSN
6505-00-171-1373
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00002-2005-33
ASPIRIN TABLETS,USP
NSN, MFG P/N
6505001711373
NSN
6505-00-171-1373
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC51079-0005-20
ASPIRIN TABLETS,USP
NSN, MFG P/N
6505001711373
NSN
6505-00-171-1373
MFG
U S DEPT OF VETERANS AFFAIRS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
2-0J31-33
PHENOBARBITAL TABLETS,USP
NSN, MFG P/N
6505001711375
NSN
6505-00-171-1375
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 15.000 MILLIGRAMS PHENOBARBITAL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOX
SPECIAL FEATURES: 10 STRIPS OF 10 EACH
Related Searches:
NDC00008-0006-02
OXAZEPAM CAPSULES,USP
NSN, MFG P/N
6505001711398
NSN
6505-00-171-1398
NDC00008-0006-02
OXAZEPAM CAPSULES,USP
NSN, MFG P/N
6505001711398
NSN
6505-00-171-1398
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.50 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 96
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 11.30 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 12
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.005 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.12 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 15.000 MILLIGRAMS OXAZEPAM ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXAZEPAM CAPSULES USP 15MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
Related Searches:
SERAX
OXAZEPAM CAPSULES,USP
NSN, MFG P/N
6505001711398
NSN
6505-00-171-1398
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.50 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 96
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 11.30 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 12
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.005 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.12 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 15.000 MILLIGRAMS OXAZEPAM ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXAZEPAM CAPSULES USP 15MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
Related Searches:
SERAX CAPSULES
OXAZEPAM CAPSULES,USP
NSN, MFG P/N
6505001711398
NSN
6505-00-171-1398
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.50 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 96
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 11.30 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 12
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.005 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.12 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 15.000 MILLIGRAMS OXAZEPAM ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: OXAZEPAM CAPSULES USP 15MG 100S
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
Related Searches:
NDC00007-5290-20
FLAVOXATE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505001723420
NSN
6505-00-172-3420
NDC00007-5290-20
FLAVOXATE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505001723420
NSN
6505-00-172-3420
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS FLAVOXATE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
COATING FEATURE: FILM, NONENTERIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLAVOXATE HYDROCHLORIDE TABLETS 100MG 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC17314-9220-01
FLAVOXATE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505001723420
NSN
6505-00-172-3420
NDC17314-9220-01
FLAVOXATE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505001723420
NSN
6505-00-172-3420
MFG
J O M INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS FLAVOXATE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
COATING FEATURE: FILM, NONENTERIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLAVOXATE HYDROCHLORIDE TABLETS 100MG 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
URISPAS
FLAVOXATE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505001723420
NSN
6505-00-172-3420
URISPAS
FLAVOXATE HYDROCHLORIDE TABLETS
NSN, MFG P/N
6505001723420
NSN
6505-00-172-3420
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS FLAVOXATE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
COATING FEATURE: FILM, NONENTERIC
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FLAVOXATE HYDROCHLORIDE TABLETS 100MG 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
LEDERPLEX
VITAMIN B COMPLEX ELIXIR
NSN, MFG P/N
6505001723426
NSN
6505-00-172-3426
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CHOLINE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS INOSITOL ACTIVE INGREDIENT AND 2.500 MILLIGRAMS NIACINAMIDE ACTIVE INGREDIENT AND 0.500 MILLIGRAMS PANTOTHENIC ACID ACTIVE INGREDIENT AND 0.050 MILLIGRAMS PYRIDOXINE HYDROCHLORIDE ACTIVE
ADMINISTRATION: ORAL
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 12.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: INGREDIENT AND 0.500 MILLIGRAMS RIBOFLAVIN ACTIVE INGREDIENT AND 0.500 MILLIGRAMS THIAMINE HYDROCHLORIDE ACTIVE INGREDIENT
Related Searches:
NDC00005-4299-63
VITAMIN B COMPLEX ELIXIR
NSN, MFG P/N
6505001723426
NSN
6505-00-172-3426
NDC00005-4299-63
VITAMIN B COMPLEX ELIXIR
NSN, MFG P/N
6505001723426
NSN
6505-00-172-3426
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CHOLINE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS INOSITOL ACTIVE INGREDIENT AND 2.500 MILLIGRAMS NIACINAMIDE ACTIVE INGREDIENT AND 0.500 MILLIGRAMS PANTOTHENIC ACID ACTIVE INGREDIENT AND 0.050 MILLIGRAMS PYRIDOXINE HYDROCHLORIDE ACTIVE
ADMINISTRATION: ORAL
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 12.000 OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: INGREDIENT AND 0.500 MILLIGRAMS RIBOFLAVIN ACTIVE INGREDIENT AND 0.500 MILLIGRAMS THIAMINE HYDROCHLORIDE ACTIVE INGREDIENT
